However, Acosta, A.M et al. (16) reported that FN1-ALK gene fusion was characteristic of pseudosarcomatous myofibroblastic proliferation, which is a novel terminology for a tumor with significant clinicopathologic differences from IMT. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.